BrainWeb provides information and links to validated sites about brain diseases and disorders from outside sources and from Dana publications.
The Dana Alliance for Brain Initiatives' Successful Aging & Your Brain program includes live public forums, printed and printable resources, and videos.
Reviews by eminent neuroscientists of specific areas of research, including normal function, disease, and new technologies.
Briefing Papers take an in-depth look at basic and timely brain-related topics, like traumatic brain injury and obesity.
(Listen to Q&A with Raymond Dingledine, Ph.D., and Bjørnar Hassel, M.D., Ph.D.)
new study has found that inhibiting an enzyme that is critical in metabolic
communication has an anti-seizure effect in epileptic mice. These findings may
very well initiate a shift to new therapeutic approaches for the many people
who suffer from seizures and convulsions and who are treatment-resistant.
People who react strongly to placebos also react strongly to antidepressants, and vice versa, according to new research. Splitting clinical trials by reactor/nonreactor might help researchers better test a potential drug’s effectiveness.
Researchers investigate an FDA-approved diabetes drug
that affects effect on energy production in cells.
Treating inherited retinal disease and deafness are likely near-term
Synaptic-level changes encode memories in the short
term. Could changes at the synapse-support structure, the PNN, encode
(Read Q&A with Richard S. Jope, Ph.D.)
The element lithium is given in capsule form as a mood stabilizer for bipolar disorder and depression. New research, however, reveals its role as a neuroprotector, and suggests that enzymes modulated by lithium could lead to new treatments for Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and other neurodegenerative disorders.